Genitourinary Cancers Following Kidney Transplant: Our 20 Years of Experience With Mechanistic Target of Rapamycin Inhibitors.

Murat Karatas,Gokalp Okut,Cenk Simsek,Sait Murat Dogan,Baha Zengel,Funda Taslı Alkan,Erhan Tatar

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation（2022）

引用 0|浏览2

暂无评分

摘要

Mechanistic target of rapamycin inhibitor-based drugs can be an important maintenance immunosuppressive treatment option for kidney transplant recipients with genitourinary cancers.

查看译文

关键词

Clinical outcomes, De novo malignancy, Graft survival, mTORi

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要